A BRISC-SHMT Complex Deubiquitinates IFNAR1 and Regulates Interferon Responses
Open accessAbstract
Lysine63-linked ubiquitin (K63-Ub) chains represent a particular ubiquitin topology that mediates proteasome-independent signaling events. The deubiquitinating enzyme (DUB) BRCC36 segregates into distinct nuclear and cytoplasmic complexes that are specific for K63-Ub hydrolysis. RAP80 targets the five-member nuclear BRCC36 complex to K63-Ub chains at DNA double-strand breaks. The alternative four-member BRCC36 containing complex (BRISC) lacks a known targeting moiety. Here, we identify serine hydroxymethyltransferase (SHMT) as a previously unappreciated component that fulfills this function. SHMT directs BRISC activity at K63-Ub chains conjugated to the type 1 interferon (IFN) receptor chain 1 (IFNAR1). BRISC-SHMT2 complexes localize to and deubiquitinate actively engaged IFNAR1, thus limiting its K63-Ub-mediated internalization and lysosomal degradation. BRISC-deficient cells and mice exhibit attenuated responses to IFN and are protected from IFN-associated immunopathology. These studies reveal a mechanism of DUB regulation and suggest a therapeutic use of BRISC inhibitors for treating pathophysiological processes driven by elevated IFN responses.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
SHMT expression is associated with immune response transcriptional programs in ACC and LGG patient cohorts.
“Previous studies have identified links between SHMT proteins and interferon signaling, and these findings indicate SHMT expression is associated with immune response transcriptional programs in ACC and LGG patient cohorts.”
From A review of small-molecule inhibitors of one-carbon enzymes: SHMT2 and MTHFD2 in the spotlight (2021) · cites this paper as [177]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Schroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475 · see citing works
Defining the Human Deubiquitinating Enzyme Interaction Landscape
Sowa, M. E., Bennett, E. J., Gygi, S. P., & Harper, J. W. (2009) · Cell · doi:10.1016/j.cell.2009.04.042 · Cited by 1,512 · see citing works
Role of Rpn11 Metalloprotease in Deubiquitination and Degradation by the 26 S Proteasome
Verma, R., Aravind, L., Oania, R. S., McDonald, W. H., Yates, J. R., Koonin, E. V., & Deshaies, R. J. (2002) · Science · doi:10.1126/science.1075898 · Cited by 994 · see citing works
Mechanism and function of deubiquitinating enzymes
Amerik, A. Y., & Hochstrasser, M. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.10.003 · Cited by 978 · see citing works
IL-1 pathways in inflammation and human diseases
Gabay, C., Lamacchia, C., & Palmer, G. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.4 · Cited by 897 · see citing works
Type I interferon: friend or foe?
Trinchieri, G. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20101664 · Cited by 838 · see citing works
A cryptic protease couples deubiquitination and degradation by the proteasome
Yao, T., & Cohen, R. E. (2002) · Nature · doi:10.1038/nature01071 · Cited by 727 · see citing works
Deubiquitination of NLRP3 by BRCC3 Critically Regulates Inflammasome Activity
Py, B. F., Kim, M.-S., Vakifahmetoglu-Norberg, H., & Yuan, J. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.11.009 · Cited by 718 · see citing works
RAP80 Targets BRCA1 to Specific Ubiquitin Structures at DNA Damage Sites
Sobhian, B., Shao, G., Lilli, D. R., Culhane, A. C., Moreau, L. A., Xia, B., Livingston, D. M., & Greenberg, R. A. (2007) · Science · doi:10.1126/science.1139516 · Cited by 672 · see citing works
The Deubiquitinating Enzyme USP1 Regulates the Fanconi Anemia Pathway
Nijman, S. M. B., Huang, T. T., Dirac, A. M. G., Brummelkamp, T. R., Kerkhoven, R. M., D’Andrea, A. D., & Bernards, R. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.01.008 · Cited by 586 · see citing works
Regulation of monoubiquitinated PCNA by DUB autocleavage
Huang, T. T., Nijman, S. M. B., Mirchandani, K. D., Galardy, P. J., Cohn, M. A., Haas, W., Gygi, S. P., Ploegh, H. L., Bernards, R., & D’Andrea, A. D. (2006) · Nature Cell Biology · doi:10.1038/ncb1378 · Cited by 585 · see citing works
A weak signal for strong responses: interferon-alpha/beta revisited
Taniguchi, T., & Takaoka, A. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35073080 · Cited by 483 · see citing works
Andrei, C., Dazzi, C., Lotti, L. V., Torrisi, M. R., Chimini, G., & Rubartelli, A. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.5.1463 · Cited by 475 · see citing works
Constitutive Type I Interferon Modulates Homeostatic Balance through Tonic Signaling
Gough, D. J., Messina, N. L., Clarke, C. J. P., Johnstone, R. W., & Levy, D. E. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.011 · Cited by 472 · see citing works
Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock
Karaghiosoff, M., Steinborn, R., Kovarik, P., Kriegshäuser, G., Baccarini, M., Donabauer, B., Reichart, U., Kolbe, T., Bogdan, C., Leanderson, T., et al. (2003) · Nature Immunology · doi:10.1038/ni910 · Cited by 363 · see citing works
A UAF1-Containing Multisubunit Protein Complex Regulates the Fanconi Anemia Pathway
Cohn, M. A., Kowal, P., Yang, K., Haas, W., Huang, T. T., Gygi, S. P., & D’Andrea, A. D. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.09.031 · Cited by 355 · see citing works
The role of ubiquitylation in receptor endocytosis and endosomal sorting
Haglund, K., & Đikić, I. (2012) · Journal of Cell Science · doi:10.1242/jcs.091280 · Cited by 310 · see citing works
Clague, M. J., & Urbé, S. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.09.002 · Cited by 258 · see citing works
Piehler, J., Thomas, C., Garcia, K. C., & Schreiber, G. (2012) · Immunological Reviews · doi:10.1111/imr.12001 · Cited by 230 · see citing works
Cooper, E. M., Cutcliffe, C., Kristiansen, T. Z., Pandey, A., Pickart, C. M., & Cohen, R. E. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.27 · Cited by 223 · see citing works
Shao, G., Lilli, D. R., Patterson-Fortin, J., Coleman, K. A., Morrissey, D. E., & Greenberg, R. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807485106 · Cited by 218 · see citing works
Regulatory mechanisms involved in the control of ubiquitin homeostasis
Kimura, Y., & Tanaka, K. (2010) · The Journal of Biochemistry · doi:10.1093/jb/mvq044 · Cited by 216 · see citing works
Deficiency of the type I interferon receptor protects mice from experimental lupus
Nacionales, D. C., Kelly‐Scumpia, K. M., Lee, P. Y., Weinstein, J. S., Lyons, R., Sobel, E. S., Satoh, M., & Reeves, W. H. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23023 · Cited by 193 · see citing works
SCFHOS ubiquitin ligase mediates the ligand‐induced down‐regulation of the interferon‐α receptor
Kumar, S., Tang, W., Ravindranath, A. K., Clark, W. A., Croze, E., & Fuchs, S. Y. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg524 · Cited by 187 · see citing works
McBride, J., Jiang, J. Z., Abbas, A. R., Morimoto, A. M., Li, J., Maciuca, R. D., Townsend, M. J., Wallace, D. J., Kennedy, W. P., & Drappa, J. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34632 · Cited by 186 · see citing works
Protein partners of deubiquitinating enzymes
Ventii, K., & Wilkinson, K. D. (2008) · Biochemical Journal · doi:10.1042/bj20080798 · Cited by 185 · see citing works
The ubiquitin system: pathogenesis of human diseases and drug targeting
Ciechanover, A. J., & Schwartz, A. L. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.09.018 · Cited by 169 · see citing works
MERIT40 controls BRCA1–Rap80 complex integrity and recruitment to DNA double-strand breaksPreprint
Shao, G., Patterson-Fortin, J., Messick, T. E., Feng, D., Shanbhag, N. M., Wang, Y., & Greenberg, R. A. (2009) · Genes & Development · doi:10.1101/gad.1739609 · Cited by 154 · see citing works
Polyubiquitin Binding and Disassembly By Deubiquitinating Enzymes
Reyes‐Turcu, F. E., & Wilkinson, K. D. (2009) · Chemical Reviews · doi:10.1021/cr800470j · Cited by 148 · see citing works
Kumar, S., Krolewski, J. J., & Fuchs, S. Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407082200 · Cited by 142 · see citing works
Liu, J., HuangFu, W., Kumar, K. G., Qian, J., Casey, J. P., Hamanaka, R. B., Grigoriadou, C., Aldabe, R., Diehl, J. A., & Fuchs, S. Y. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2008.11.008 · Cited by 135 · see citing works
Site-specific ubiquitination exposes a linear motif to promote interferon-α receptor endocytosis
Kumar, S., Barrière, H., Carbone, C. J., Liu, J., Swaminathan, G., Xu, P., Li, Y., Baker, D. P., Peng, J., Lukács, G. L., et al. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200706034 · Cited by 135 · see citing works
Agrawal, H., Jacob, N., Carreras, E., Bajaña, S., Putterman, C., Turner, S., Neas, B. R., Mathian, A., Koss, M. N., Stohl, W., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803872 · Cited by 130 · see citing works
Feng, L., Wang, J., & Chen, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.135392 · Cited by 122 · see citing works
Watkins, L. R., Hansen, M. K., Nguyen, K. T., Lee, J. E., & Maier, S. F. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00095-8 · Cited by 114 · see citing works
Differential regulation of JAMM domain deubiquitinating enzyme activity within the RAP80 complex
Patterson-Fortin, J., Shao, G., Bretscher, H., Messick, T. E., & Greenberg, R. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.135319 · Cited by 85 · see citing works
Neutralizing interferon alpha as a therapeutic approach to autoimmune diseases
Stewart, T. A. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00088-6 · Cited by 85 · see citing works
Hope and Fear for Interferon: The Receptor-Centric Outlook on the Future of Interferon Therapy
Fuchs, S. Y. (2013) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2012.0117 · Cited by 80 · see citing works
Ligand-Stimulated Downregulation of the Alpha Interferon Receptor: Role of Protein Kinase D2
Zheng, H., Qian, J., Varghese, B., Baker, D. P., & Fuchs, S. Y. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01154-10 · Cited by 75 · see citing works
Cooper, E. M., Boeke, J. D., & Cohen, R. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.059667 · Cited by 65 · see citing works
Kumar, K. G., Varghese, B., Banerjee, A., Baker, D. P., Constantinescu, S. N., Pellegrini, S., & Fuchs, S. Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800991200 · Cited by 50 · see citing works
Scheer, J. B., Mackey, A. D., & Gregory, J. F. (2005) · Journal of Nutrition · doi:10.1093/jn/135.2.233 · Cited by 48 · see citing works
Ligand-independent pathway that controls stability of interferon alpha receptor
Liu, J., Plotnikov, A., Banerjee, A., Kumar, K. G., Ragimbeau, J., Marijanovic, Z., Baker, D. P., Pellegrini, S., & Fuchs, S. Y. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.12.137 · Cited by 47 · see citing works
Goldman, L. A., Zafari, M. R., Cutrone, E. C., Dang, A. M., Brickelmeier, M., Runkel, L., Benjamin, C. D., Ling, L. E., & Langer, J. A. (1999) · Journal of Interferon & Cytokine Research · doi:10.1089/107999099314379 · Cited by 44 · see citing works
Pathogen Recognition Receptor Signaling Accelerates Phosphorylation-Dependent Degradation of IFNAR1
Qian, J., Zheng, H., HuangFu, W., Liu, J., Carbone, C. J., Leu, N. A., Baker, D. P., & Fuchs, S. Y. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002065 · Cited by 44 · see citing works
Ubiquitination-Dependent Regulation of Signaling Receptors in Cancer
HuangFu, W., & Fuchs, S. Y. (2010) · Genes & Cancer · doi:10.1177/1947601910382901 · Cited by 42 · see citing works
Ubiquitination-mediated regulation of interferon responses
Fuchs, S. Y. (2012) · Growth Factors · doi:10.3109/08977194.2012.669382 · Cited by 38 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Serine and glycine metabolism in cancer
Amelio, I., Cutruzzolà, F., Antonov, A., Agostini, M., & Melino, G. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.02.004 · Cited by 1,056 · see citing works
Breaking the chains: deubiquitylating enzyme specificity begets function
Clague, M. J., Urbé, S., & Komander, D. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0099-1 · Cited by 839 · see citing works
The role of mitochondria in NLRP3 inflammasome activation
Liu, Q., Zhang, D., Hu, D., Zhou, X., & Zhou, Y. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.09.010 · Cited by 475 · see citing works
Deubiquitinases: From mechanisms to their inhibition by small molecules
Lange, S. M., Armstrong, L. A., & Kulathu, Y. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.10.027 · Cited by 344 · see citing works
The ins and outs of serine and glycine metabolism in cancer
Geeraerts, S. L., Heylen, E., Keersmaecker, K. D., & Kampen, K. R. (2021) · Nature Metabolism · doi:10.1038/s42255-020-00329-9 · Cited by 250 · see citing works
Versatile Roles of K63-Linked Ubiquitin Chains in Trafficking
Erpapazoglou, Z., Walker, O., & Haguenauer‐Tsapis, R. (2014) · Cells · doi:10.3390/cells3041027 · Cited by 203 · see citing works
Targeted inhibition of the COP9 signalosome for treatment of cancer
Schlierf, A., Altmann, E., Quancard, J., Jefferson, A. B., Assenberg, R., Renatus, M., Jones, M. D., Hassiepen, U., Schaefer, M., Kiffe, M., et al. (2016) · Nature Communications · doi:10.1038/ncomms13166 · Cited by 192 · see citing works
Deacetylation of serine hydroxymethyl-transferase 2 by SIRT3 promotes colorectal carcinogenesis
Wei, Z., Song, J., Wang, G., Cui, X., Zheng, J., Tang, Y., Chen, X., Li, J., Cui, L., Liu, C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06812-y · Cited by 188 · see citing works
HDAC11 regulates type I interferon signaling through defatty-acylation of SHMT2
Cao, J., Sun, L., Aramsangtienchai, P., Spiegelman, N. A., Zhang, X., Huang, W., Seto, E., & Lin, H. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1815365116 · Cited by 189 · see citing works
ABRO1 promotes NLRP3 inflammasome activation through regulation of NLRP3 deubiquitination
Ren, G., Zhang, X., Xiao, Y., Zhang, W., Wang, Y., Ma, W., Wang, X., Song, P., Lai, L., Chen, H., et al. (2019) · The EMBO Journal · doi:10.15252/embj.2018100376 · Cited by 154 · see citing works
Li, L., Wei, Y., To, C., Zhu, C., Tong, J., Pham, N., Taylor, P. P., Ignatchenko, V., Ignatchenko, A., Zhang, W., et al. (2014) · Nature Communications · doi:10.1038/ncomms6469 · Cited by 115 · see citing works
Giardina, G., Brunotti, P., Fiascarelli, A., Cicalini, A., Costa, M. G. S., Buckle, A. M., di Salvo, M. L., Giorgi, A., Marani, M., Paone, A., et al. (2015) · FEBS Journal · doi:10.1111/febs.13211 · Cited by 104 · see citing works
Metabolic Regulation of Cell Fate and Function
Ghosh-Choudhary, S. K., Liu, J., & Finkel, T. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2019.12.005 · Cited by 106 · see citing works
Regulatory mechanisms of one-carbon metabolism enzymes
Petrova, B., Maynard, A. G., Wang, P., & Kanarek, N. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105457 · Cited by 103 · see citing works
Mechanisms of regulation and diversification of deubiquitylating enzyme function
Leźnicki, P., & Kulathu, Y. (2017) · Journal of Cell Science · doi:10.1242/jcs.201855 · Cited by 97 · see citing works
Guo, T., Zuo, Y., Qian, L., Liu, J., Yuan, Y., Xu, K., Miao, Y., Feng, Q., Chen, X., Jin, L., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0428-3 · Cited by 97 · see citing works
Metabolic control of BRISC-SHMT2 assembly regulates immune signalling
Walden, M., Tian, L., Ross, R. L., Sykora, U. M., Byrne, D. P., Hesketh, E. L., Masandi, S. K., Cassel, J., George, R., Ault, J. R., et al. (2019) · Nature · doi:10.1038/s41586-019-1232-1 · Cited by 85 · see citing works
Ren, G., Li, J., Zhang, X., Wang, Y., Xiao, Y., Zhang, X., Liu, X., Zhang, W., Ma, W., Zhang, J., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abe2933 · Cited by 87 · see citing works
Structural basis of BRCC36 function in DNA repair and immune regulation
Rabl, J., Bunker, R. D., Schenk, A. D., Cavadini, S., Gill, M. E., Abdulrahman, W., Andrés-Pons, A., Luijsterburg, M. S., Ibrahim, A. F. M., Branigan, E., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.06.002 · Cited by 84 · see citing works
Núñez‐Álvarez, Y., & Suelves, M. (2021) · FEBS Journal · doi:10.1111/febs.15895 · Cited by 82 · see citing works
Role of Deubiquitinating Enzymes in DNA Repair
Kee, Y., & Huang, T. T. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00847-15 · Cited by 80 · see citing works
Liu, C., Wang, L., Liu, X., Tan, Y., Tao, L., Xiao, Y., Deng, P., Wang, H., Deng, Q., Lin, Y., et al. (2021) · Theranostics · doi:10.7150/thno.48699 · Cited by 76 · see citing works
Type I Interferon Controls Propagation of Long Interspersed Element-1
Yu, Q., Carbone, C. J., Katlinskaya, Y. V., Zheng, H., Zheng, K., Luo, M., Wang, P. J., Greenberg, R. A., & Fuchs, S. Y. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.612374 · Cited by 76 · see citing works
Higher-Order Assembly of BRCC36–KIAA0157 Is Required for DUB Activity and Biological Function
Zeqiraj, E., Tian, L., Piggott, C. A., Pillon, M. C., Duffy, N. M., Ceccarelli, D. F. J., Keszei, A. F. A., Lorenzen, K., Kurinov, I. V., Orlicky, S. M., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.07.028 · Cited by 66 · see citing works
Xu, S., Wu, X. Y., Wu, L., Castillo, A., Liu, J., Atkinson, E., Paul, A., Su, D., Schlacher, K., Komatsu, Y., et al. (2017) · Genes & Development · doi:10.1101/gad.299172.117 · Cited by 65 · see citing works
Roles of Mitochondrial Serine Hydroxymethyltransferase 2 (SHMT2) in Human Carcinogenesis
Zeng, Y., Zhang, J., Xu, M., Chen, F., Zi, R., Yue, J., Zhang, Y., Chen, N., & Chin, Y. E. (2021) · Journal of Cancer · doi:10.7150/jca.60170 · Cited by 62 · see citing works
Chen, J., Na, R., Xiao, C. W., Wang, X., Wang, Y., Yan, D., Song, G., Liu, X., Chen, J., Lu, H., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01815-4 · Cited by 61 · see citing works
Hidden features: exploring the non-canonical functions of metabolic enzymes
Huangyang, P., & Simon, M. C. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.033365 · Cited by 59 · see citing works
ABRO1 suppresses tumourigenesis and regulates the DNA damage response by stabilizing p53
Zhang, J., Cao, M., Dong, J., Li, C., Xu, W., Zhan, Y., Wang, X., Yu, M., Ge, C., Ge, Z., et al. (2014) · Nature Communications · doi:10.1038/ncomms6059 · Cited by 58 · see citing works
A review of small-molecule inhibitors of one-carbon enzymes: SHMT2 and MTHFD2 in the spotlight
Cuthbertson, C. R., Arabzada, Z., Bankhead, A., Kyani, A., & Neamati, N. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00223 · Cited by 57 · see citing works
Yan, K., Li, L., Wang, X., Hong, R.-S., Zhang, Y., Yang, H., Lin, M. T., Zhang, S., He, Q., Zheng, D., et al. (2015) · The Journal of Cell Biology · doi:10.1083/jcb.201503039 · Cited by 53 · see citing works
Xu, M., Moresco, J. J., Chang, M. W., Mukim, A., Smith, D. M., Diedrich, J. K., Yates, J. R., & Jones, K. A. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007071 · Cited by 49 · see citing works
Belle, J. I., & Nijnik, A. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.03.004 · Cited by 44 · see citing works
Overexpression of SHMT2 predicts a poor prognosis and promotes tumor cell growth in bladder cancer
Zhang, P., & Yang, Q. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.682856 · Cited by 41 · see citing works
Zhang, W., Liu, K., Ren, G., Wang, Y., Wang, T., Liu, X., Li, D., Xiao, Y., Chen, X., Li, Y., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06268-z · Cited by 40 · see citing works
Pseudo-DUBs as allosteric activators and molecular scaffolds of protein complexes
Walden, M., Masandi, S. K., Pawłowski, K., & Zeqiraj, E. (2018) · Biochemical Society Transactions · doi:10.1042/bst20160268 · Cited by 39 · see citing works
Structural and Functional Basis of JAMM Deubiquitinating Enzymes in Disease
Pan, X., Wu, S., Wei, W., Chen, Z.-X., Wu, Y., & Gong, K.-Z. (2022) · Biomolecules · doi:10.3390/biom12070910 · Cited by 35 · see citing works
Mechanisms orchestrating the enzymatic activity and cellular functions of deubiquitinases
Estavoyer, B., Messmer, C., Echbicheb, M., Rudd, C. E., Milot, É., & Affar, E. B. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102198 · Cited by 37 · see citing works
Lysine Fatty Acylation: Regulatory Enzymes, Research Tools, and Biological Function
Komaniecki, G., & Lin, H. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.717503 · Cited by 37 · see citing works
Deubiquitinases and cancer: A snapshot
Singh, N., & Singh, A. B. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.04.018 · Cited by 36 · see citing works
Rajamäki, K., Keskitalo, S., Seppänen, M. R. J., Kuismin, O., Vähäsalo, P., Trotta, L., Väänänen, A., Glumoff, V., Keskitalo, P. L., Kaarteenaho, R. L., et al. (2018) · RMD Open · doi:10.1136/rmdopen-2018-000740 · Cited by 34 · see citing works
Donaghy, R., Han, X., Rozenova, K., Lv, K., Jiang, Q., Doepner, M., Greenberg, R. A., & Tong, W. (2019) · Blood · doi:10.1182/blood-2018-10-877563 · Cited by 33 · see citing works
Metformin Is a Pyridoxal-5′-phosphate (PLP)-Competitive Inhibitor of SHMT2
Tramonti, A., Cuyàs, E., Encinar, J. A., Pietzke, M., Paone, A., Verdura, S., Arbusà, A., Martı́n-Castillo, B., Giardina, G., Joven, J., et al. (2021) · Cancers · doi:10.3390/cancers13164009 · Cited by 31 · see citing works
Fang, Y.-Z., Li, J., He, Q., Cao, J., & Yang, B. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.02.019 · Cited by 32 · see citing works
BRCA1-A and BRISC: multifunctional molecular machines for ubiquitin signaling
Rabl, J. (2020) · Biomolecules · doi:10.3390/biom10111503 · Cited by 31 · see citing works
Fine-tuning the ubiquitin code at DNA double-strand breaks: deubiquitinating enzymes at work
Citterio, E. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00282 · Cited by 29 · see citing works
Serine hydroxymethyltransferase 2: a novel target for human cancer therapy
Xie, M., & Pei, D. (2021) · Investigational New Drugs · doi:10.1007/s10637-021-01144-z · Cited by 30 · see citing works
Functional characterization of BRCC3 mutations in acute myeloid leukemia with t(8;21)(q22;q22.1)
Meyer, T., Jahn, N., Lindner, S., Röhner, L., Dolnik, A., Weber, D., Scheffold, A., Köpff, S., Paschka, P., Gaidzik, V. I., et al. (2019) · Leukemia · doi:10.1038/s41375-019-0578-6 · Cited by 27 · see citing works
Ubiquitination network in the type I IFN‐induced antiviral signaling pathway
Zhao, Q., Zhang, R., Qiao, C., Miao, Y., Yuan, Y., & Zheng, H. (2023) · European Journal of Immunology · doi:10.1002/eji.202350384 · Cited by 27 · see citing works
MERIT40 cooperates with BRCA2 to resolve DNA interstrand cross-linksPreprint
Jiang, Q., Paramasivam, M., Aressy, B., Wu, J., Bellani, M. A., Tong, W., Seidman, M. M., & Greenberg, R. A. (2015) · Genes & Development · doi:10.1101/gad.264192.115 · Cited by 26 · see citing works
Three-Dimensional Architecture of the Human BRCA1-A Histone Deubiquitinase Core Complex
Kyrieleis, O. J. P., McIntosh, P. B., Webb, S. R., Calder, L. J., Lloyd, J., Patel, N. A., Martin, S. R., Robinson, C. V., Rosenthal, P. B., & Smerdon, S. J. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.11.063 · Cited by 25 · see citing works
Cancer proteome and metabolite changes linked to SHMT2
Tong, J., Krieger, J. R., Taylor, P., Bagshaw, R., Kang, J., Jeedigunta, S., Wybenga-Groot, L. E., Zhang, W., Badr, H., Mirhadi, S., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237981 · Cited by 24 · see citing works
Nair, S., Bist, P., Dikshit, N., & Krishnan, M. N. (2016) · Scientific Reports · doi:10.1038/srep36179 · Cited by 24 · see citing works
Deubiquitinases in cell death and inflammation
Newton, K., & Gitlin, A. D. (2022) · Biochemical Journal · doi:10.1042/bcj20210735 · Cited by 25 · see citing works
Zhang, W., Tao, S., Wang, T., Zhang, J., Liu, X., Li, Y., Chen, H., Zhan, Y., Yu, M., Ge, C., et al. (2020) · FEBS Letters · doi:10.1002/1873-3468.13970 · Cited by 22 · see citing works
TRIM10 binds to IFN‐α/β receptor 1 to negatively regulate type I IFN signal transduction
Guo, M., Cao, W., Chen, S., Tian, R., Wang, L., Liu, Q., Zhang, L., Wang, Z., Zhao, M., Lu, Q., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202049073 · Cited by 18 · see citing works
Zhang, L., Huang, F., Liu, J., Xu, Y., Miao, Y., Yuan, Y., Chen, X., Zhang, H.-G., Wang, J., Zheng, H., et al. (2021) · Molecular Immunology · doi:10.1016/j.molimm.2021.03.027 · Cited by 17 · see citing works
Molecular Pathogenic Mechanisms of Hypomyelinating Leukodystrophies (HLDs)
Torii, T., & Yamauchi, J. (2023) · Neurology International · doi:10.3390/neurolint15030072 · Cited by 16 · see citing works
One-carbon metabolism in cancer: moonlighting functions of metabolic enzymes and anti-tumor therapy
Cao, X., Guo, Y., Guo, Z., Liu, Y., Dou, Y., & Xue, L. (2025) · Cancer and Metastasis Reviews · doi:10.1007/s10555-025-10308-9 · Cited by 16 · see citing works
Phosphorylated SHMT2 Regulates Oncogenesis Through m6A Modification in Lung Adenocarcinoma
Han, T., Wang, Y., Cheng, M., Hu, Q., Wan, X., Huang, M.-L., Liu, Y., Xun, W., Xu, J., Wang, L., et al. (2024) · Advanced Science · doi:10.1002/advs.202307834 · Cited by 14 · see citing works
Regulatory interplay between deubiquitinating enzymes and cytokines
Woo, B., & Baek, K. (2019) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2019.06.001 · Cited by 15 · see citing works
Pandit, P., Galande, S., & Iris, F. (2021) · Journal of Nutritional Science · doi:10.1017/jns.2021.83 · Cited by 14 · see citing works
Qian, G., Zhu, L., Li, G. L., Liu, Y., Zhang, Z., Pan, J., & Lv, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.742542 · Cited by 13 · see citing works
Estrogen-responsive genes for environmental studies
Kiyama, R., Zhu, Y., Kawaguchi, K., Iitake, N., Wada‐Kiyama, Y., & Dong, S. (2014) · Environmental Technology & Innovation · doi:10.1016/j.eti.2014.09.001 · Cited by 13 · see citing works
Spike S1 domain interactome in non-pulmonary systems: A role beyond the receptor recognition
Iacobucci, I., Monaco, V., Canè, L., Bibbò, F., Cioffi, V., Cozzolino, F., Guarino, A., Zollo, M., & Monti, M. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.975570 · Cited by 12 · see citing works
Molecular glues that inhibit deubiquitylase activity and inflammatory signaling
Chandler, F., Reddy, P. A. N., Bhutda, S., Ross, R. L., Datta, A., Walden, M., Walker, K., Donato, S. D., Cassel, J. A., Prakesch, M. A., et al. (2025) · Nature Structural & Molecular Biology · doi:10.1038/s41594-025-01517-5 · Cited by 10 · see citing works
Lu, L., Guo, Y., Wang, T., Liang, L., Zhao, S., Wang, F., & Liu, L. (2019) · Science China Chemistry · doi:10.1007/s11426-019-9623-0 · Cited by 10 · see citing works
Rozenova, K., Jiang, J., Donaghy, R., Aressy, B., Greenberg, R. A., & Tong, W. (2015) · Blood · doi:10.1182/blood-2014-07-588145 · Cited by 9 · see citing works
Protein Post‐Translational Modification‐Mediated Control of Type I Interferon Cascade Signaling
Chen, X., Cheng, Q., Gong, F., & Zheng, H. (2025) · Medicine Bulletin · doi:10.1002/mdb2.70000 · Cited by 9 · see citing works
BRCA1-A and LIG4 complexes mediate ecDNA biogenesis and cancer drug resistance
Chung, O. W., Yao, S., Wang, L., Yang, F., Schier, L., Aldana, M., Cerda-Smith, C. G., Hutchinson, H. M., Wood, K. C., Su, W., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2530443123 · Cited by 9 · see citing works
Wang, B., Li, M., Cao, D., Sun, Q., Yu, W.-J., Ma, J., Ren, H., Xu, G., & Zhou, L. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05390-1 · Cited by 8 · see citing works
SHMT proteins: An emerging set of serine hydroxymethyltransferase in cancer
Fu, R., Sun, F., Wang, W., Wang, R., Zhang, H., He, X., Liu, A., & Yang, L. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111977 · Cited by 7 · see citing works
Cheng, Q., Feng, Q., Xu, Y., Zuo, Y., Liu, J., Yuan, Y., Miao, Y., Liu, Y., Lei, L., Guo, T., et al. (2020) · European Journal of Immunology · doi:10.1002/eji.202048537 · Cited by 7 · see citing works
Mahajan, S., Majumder, A., Stewart, P. A., Chen, Y. A., Adhikari, E., Fang, B., Yan, Y., Lawrence, H. R., Kinose, F., Koomen, J. M., et al. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.2c00018 · Cited by 6 · see citing works
The PKR-Like Endoplasmic Reticulum Kinase Promotes the Dissemination of Myc-Induced Leukemic Cells
Gui, J., Katlinski, K. V., Koumenis, C., Diehl, J. A., & Fuchs, S. Y. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0002 · Cited by 6 · see citing works
Pan, X., Sun, Y., Liu, J., Chen, R., Zhang, Z., Li, C., Yao, H., & Ma, J. (2025) · Autophagy · doi:10.1080/15548627.2025.2468140 · Cited by 5 · see citing works
Different HCV Exposure Drives Specific miRNA Profile in PBMCs of HIV Patients
Valle‐Millares, D., Brochado‐Kith, O., Martín‐Carbonero, L., Domínguez, L., Ryan, P., Santos, I. D. L., de la Fuente, S., Castro, J. M., Lagarde, M., Cuevas, G., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9111627 · Cited by 4 · see citing works
Zheng, D., Xie, W., Li, L., Jiang, W., Zou, Y., Chiang, C., Shao, G., & Yan, K. (2018) · Cell Biology International · doi:10.1002/cbin.11086 · Cited by 4 · see citing works
Identification of BRCC3 and BRCA1 as Regulators of TAZ Stability and Activity
Sberna, S., Lopez-Hernandez, A., Biancotto, C., Motta, L., Andronache, A., Verhoef, L. G. G. C., Cagánová, M., & Campaner, S. (2023) · Cells · doi:10.3390/cells12202431 · Cited by 3 · see citing works
Wang, T., Lin, P., Wang, Y., Lai, X., Chen, P., Li, F., & Feng, J. (2023) · Aquaculture International · doi:10.1007/s10499-023-01375-2 · Cited by 2 · see citing works
Genetics of Moyamoya Beyond RNF213: Monogenic Moyamoya Syndromes
Guey, S., Kraemer, M., Grangeon, L., Riant, F., Kossorotoff, M., Hervé, D., & Tournier‐Lasserve, E. (2017) · Current topics in environmental health and preventive medicine · doi:10.1007/978-981-10-2711-6_9 · Cited by 2 · see citing works
Loss of SHMT2 mediates 5-FU chemoresistance by inducing autophagy in colorectal cancerPreprint
Chen, J., Fan, G., Xiao, C. W., Wang, X., Wang, Y., Song, G., Liu, X., Chen, J., Lu, H., Guo, W.-P., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/680892 · Cited by 2 · see citing works
Zhang, X., Pang, X., Chen, Y., Liu, G., Huang, J., & Zeng, Y. (2025) · Biomolecules · doi:10.3390/biom15121724 · Cited by 1 · see citing works
The Role of One‐Carbon Metabolism in Cancer and Its Therapeutic Significance
Jiang, Y., Zhou, G., Zhang, Q., & Zhou, S. (2026) · MedComm – Oncology · doi:10.1002/mog2.70062 · Cited by 1 · see citing works
Mechanism of K63-linked polyubiquitin recognition and cleavage by the BRCA1-A complex
Foglizzo, M., Datta, A., Degtjarik, O., Perera, H., Liburd, J., Sykora, U. M., Ganji, S. R., Wildsmith, G. C., Chandler, F., Campbell, L. J., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-75795-y · Cited by 1 · see citing works
Boumis, G., Breccia, S., Pistoia, G., Spizzichino, S., Zamparelli, C., Troilo, F., Matteo, A. D., Travaglini‐Allocatelli, C., Contestabile, R., Tramonti, A., et al. (2026) · Frontiers in Chemical Biology · doi:10.3389/fchbi.2026.1941005 · Cited by 1 · see citing works
The Crossroads of Ubiquitination and DNA Repair: A Structural Perspective
Lingaraju, G. M., Böhm, K., Rabl, J., Cavadini, S., Fischer, E. S., Kassube, S. A., & Thomä, N. H. (2016) · Springer eBooks · doi:10.1007/978-4-431-55873-6_9 · Cited by 1 · see citing works
BRISC inactivation alleviates alcohol-induced liver injury in mice
Wang, T., Zhang, W., Liu, X., Liu, K., Ren, G., Xiang, S., Zhan, Y., Chen, H., Gao, H., Zhao, K., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-89796-2 · Cited by 1 · see citing works
Xu, X., Chen, Y., Li, Y., Zhao, S., & Wang, C. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.20.599818 · Cited by 1 · see citing works
Transcriptional regulation of human abraxas brother protein 1 expression by yin yang 1
Song, P., Hong, J., Wang, Y., Yao, X., Zhan, Y., Yin, R., Yu, M., Li, C., Yang, X., & Ge, C. (2020) · Biochemistry and Cell Biology · doi:10.1139/bcb-2019-0279
Interaction Analysis of SHMT1/2 Gene Variants with HCC in Chinese PatientsPreprint
Sun, Y., Gao, J., Shi, C., Liu, X., Zhang, F., Shi, X., Wang, Y., He, Y., Guo, W.-Z., & Zhang, S. (2022) · Research Square · doi:10.21203/rs.3.rs-2197291/v1
Miao, Y., Yuan, Y., Chen, Y., Liu, J., Fan, H., Zhang, T., Zhang, R., Zhao, Q., Cui, Q., Tian, W., et al. (2024) · medRxiv · doi:10.1101/2024.06.14.24308555
Molecular glues that inhibit deubiquitylase activity and inflammatory signallingPreprint
Chandler, F., Reddy, P. A. N., Bhutda, S., Ross, R. L., Datta, A., Walden, M., Walker, K., Donato, S. D., Cassel, J. A., Prakesch, M. A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.07.611787
Small-molecule glues selectively restrict deubiquitylase activity and inflammatory signaling
(2025) · Nature Structural & Molecular Biology · doi:10.1038/s41594-025-01518-4
Rawlings, N. D. (2025) · Handbook of Proteolytic Enzymes · doi:10.1016/b978-0-443-28849-4.00290-3
Proximity labeling reveals non-catalytic interactions between DPP9 and ubiquitin signaling complexes
Wirtgen, V. E., Saied, L., Zolg, S., Alonso, M. C., Mayer, B. A., Donzelli, L., Maurer, U., Timmers, H. T. M., Knobeloch, K., Kleifeld, O., et al. (2026) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-06021-z
Zhang, W., Wang, Y., Feng, T., Cai, T., Wang, W., Zhu, S., Chen, Y., Zhang, H., Ye, D., Wang, C., et al. (2026) · Cell Death and Differentiation · doi:10.1038/s41418-026-01704-x
Li, J.-Y., Zhang, X., & Sheng, R. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08044-x · Cited by 1 · see citing works
Wang, Q., Tian, J., Liu, D., Zheng, T., Liu, X. M., Zhao, Y., Li, X., Zhong, H., Pan, J., Yuan, C., et al. (2026) · Circulation · doi:10.1161/circulationaha.125.066183
- Authors
- Zheng, H., Gupta, V., Patterson-Fortin, J., Bhattacharya, S., Katlinski, K., Wu, J., Varghese, B., Carbone, C. J., Aressy, B., Fuchs, S. Y., & Greenberg, R. A.
- Affiliations
- University of Pennsylvania (US)
- Corresponding author
- Fuchs, Serge Y.
- Greenberg, Roger A.
- Venue
- Cell Reports
- Publisher
- Elsevier BV
- Published
- 2013-10
- Volume
- 5
- Issue
- 1
- Pages
- 180-193
- ISSN
- 2211-1247 (ISSN-L)
- PMC
- PMC3813903
- OpenAlex
- W2071829053
- Cited by
- 101
- References
- 47
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 5 · 2023: 7 · 2022: 6 · 2021: 18 · 2020: 6 · 2019: 12 · 2018: 7 · 2017: 3 · 2016: 5 · 2015: 8 · 2014: 6
- FWCI
- 2.83
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cell Reports (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- U.S. Department of Defense
- American Cancer Society
- University of Pennsylvania
- Breast Cancer Coalition of Rochester
- National Institutes of Health
- Harrington Discovery Institute, University Hospitals
- National Cancer Institute (R01CA138835, CA17494, CA 092900, R01CA092900, CA142425, CA138835, R01CA142425, R01CA174904)
- National Institute of General Medical Sciences (GM101149, R01GM101149)
- Abramson Family Cancer Research Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- BRCC36, serine hydroxymethyltransferase, SHMT2, deubiquitination, K63-linked ubiquitin, IFNAR1, type I interferon signaling, lysosomal degradation
- MeSH terms
- Animals, Female, HeLa Cells, Humans, Interferons, Membrane Proteins, Mice, Inbred C57BL, Glycine Hydroxymethyltransferase, Ubiquitins, RNA, Small Interfering, Multiprotein Complexes, Mice, Receptor, Interferon alpha-beta, Ubiquitination, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review